Format

Send to

Choose Destination
See comment in PubMed Commons below
Haematologica. 2011 Jul;96(7):1067-71. doi: 10.3324/haematol.2010.039214.

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases.

Author information

1
German Study Group on Post-transplant Lymphoproliverative Disorders (DPTLDSG), University Medical Center Schleswig-Holstein, Campus Kiel, Department of Internal Medicine II: Hematology and Oncology, Arnold-Heller Strasse 3, 24105 Kiel, Germany. ralf.trappe@uk-sh.de

Abstract

Post-transplantation lymphoproliferative disorder (PTLD) with plasmacellular differentiation has been reported as a rare subtype of monomorphic B-cell post-transplant lympho-proliferation with histological and immunophenotypical features of plasmacytoma in the non-transplant population. Here we present clinical, laboratory and histopathological features, treatment and outcome of 8 patients from the German prospective PTLD registry. Clinically, extranodal manifestations were common while osteolytic lesions were rare and none of the patients had bone marrow involvement. Immunohistochemistry showed light chain restriction and expression of CD138 without CD20 expression in all samples. An association with Epstein-Barr virus was found in 3 out of 8 cases. We suggest that the Ann Arbor classification is most useful for this disease entity and report a generally good response to treatment including reduction of immuno-suppression, surgery and irradiation in localized disease and systemic chemotherapy analogous to plasmacell myeloma in advanced disease.

PMID:
21719885
PMCID:
PMC3128229
DOI:
10.3324/haematol.2010.039214
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center